These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 4155419)

  • 21. Survey of primary dapsone-resistant leprosy.
    Wang HY; Li WZ; Yang LH; Huang HS; Lu WQ; Yu LC
    Proc Chin Acad Med Sci Peking Union Med Coll; 1986; 1(3):173-5. PubMed ID: 3321049
    [No Abstract]   [Full Text] [Related]  

  • 22. [Prevalence of dapsone-resistant leprosy in Burundi. Temporary results].
    Bourland J; Van Loo L; Pattyn SR
    Acta Leprol; 1982; (86-87):29-33. PubMed ID: 6815995
    [No Abstract]   [Full Text] [Related]  

  • 23. Studies on murine leprosy bacillus. 8. Reproduction test of the diseases in mice using graded doses of the 6th subculture of the supposed Hawaiian strain of Mycobacterium lepraemurium.
    Ogawa T; Hiraki M
    Kitasato Arch Exp Med; 1973 Jun; 46(1):1-13. PubMed ID: 4602931
    [No Abstract]   [Full Text] [Related]  

  • 24. A preliminary report on a therapeutic trial with acedapsone in lepromatous leprosy.
    Ramanujam K; Iyer CG; Ramu G
    Lepr Rev; 1975 Jun; 46(2 Suppl):85-7. PubMed ID: 1100969
    [No Abstract]   [Full Text] [Related]  

  • 25. Do leprosy patients in Papua New Guinea take their dapsone?
    Ree GH; Taylor VE
    P N G Med J; 1979; 22(2):145-7. PubMed ID: 399578
    [No Abstract]   [Full Text] [Related]  

  • 26. I.C.M.R. conference on leprosy research.
    Lepr India; 1978 Jul; 50(3):428-51. PubMed ID: 29989
    [No Abstract]   [Full Text] [Related]  

  • 27. The neonatally thymectomized rat as a model of the lepromatous patient.
    Gelber RH
    Int J Lepr Other Mycobact Dis; 1987 Dec; 55(4 Suppl):879-81. PubMed ID: 3325582
    [No Abstract]   [Full Text] [Related]  

  • 28. Partial inhibition of the growth of Mycobacterium lepraemurium in C3H mice immunized with cell wall skeletons.
    Tanaka Y
    Int J Lepr Other Mycobact Dis; 1979 Sep; 47(3):486-94. PubMed ID: 385517
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dapsone resistance in leprosy.
    Browne SG
    Trans St Johns Hosp Dermatol Soc; 1973; 59(2):225-9. PubMed ID: 4602407
    [No Abstract]   [Full Text] [Related]  

  • 30. Importance of nasal lesions in early lepromatous leprosy.
    Barton RP
    Ann R Coll Surg Engl; 1975 Dec; 57(6):309-12. PubMed ID: 1108744
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dapsone-resistant Mycobacterium leprae in a patient receiving dapsone in low doses.
    Browne SG
    Int J Lepr Other Mycobact Dis; 1969; 37(3):296-301. PubMed ID: 4906048
    [No Abstract]   [Full Text] [Related]  

  • 32. Experimental chemotherapy in leprosy, then and now.
    Shepard CC
    Int J Lepr Other Mycobact Dis; 1973; 41(3):307-19. PubMed ID: 4136732
    [No Abstract]   [Full Text] [Related]  

  • 33. [Efficacy of a daily dosage of dapsone combined with a single dose of rifampicin. Clinical, bacteriological and histopathological evaluation].
    Le KD; Nguyen N; Nguyen VM
    Acta Leprol; 1981; 85():75-82. PubMed ID: 6805238
    [No Abstract]   [Full Text] [Related]  

  • 34. [2 cases of paucibacillary leprosy resistant to dapsone].
    Janssens L
    Acta Leprol; 1982; (86-87):181-3. PubMed ID: 6815986
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Peroxidase in therapy of experimentally induced leprosy.
    Maslov AK; Luzhnova SA; Kalyanina OV
    Int J Lepr Other Mycobact Dis; 2001 Mar; 69(1):49-52. PubMed ID: 11480320
    [No Abstract]   [Full Text] [Related]  

  • 36. Long-term treatment of dapsone-resistant leprosy with rifampicin: clinical and bacteriological studies.
    Rees RJ; Waters MF; Pearson JM; Helmy HS; Laing AB
    Int J Lepr Other Mycobact Dis; 1976; 44(1-2):159-69. PubMed ID: 776852
    [No Abstract]   [Full Text] [Related]  

  • 37. [Resistance of Mycobacterium leprae to sulfones (DDS) and rifampicin in recurring lepromatous leprosy in Martinique and Guadeloupe since February 1980].
    Guelpa-Lauras CC; Constant-Desportes M; Millan J; Grosset J
    Acta Leprol; 1982; (86-87):77-80. PubMed ID: 6816000
    [No Abstract]   [Full Text] [Related]  

  • 38. New prospects for the study of leprosy in the laboratory.
    Rees RJ
    Bull World Health Organ; 1969; 40(5):785-800. PubMed ID: 4898388
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The impact of experimental human leprosy in the mouse on leprosy research.
    Rees RJ
    Int J Lepr Other Mycobact Dis; 1971; 39(2):201-15. PubMed ID: 4948076
    [No Abstract]   [Full Text] [Related]  

  • 40. The clinical diagnosis of dapsone resistant leprosy.
    Taylor PM
    Lepr India; 1982 Jan; 54(1):117-22. PubMed ID: 7047897
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.